The FDA identifies company whose exosome products sickened patients last year, issues stern warning

from Medpage Today by Kristina Fiore

The FDA has identified Las Vegas-based EUCYT Laboratories as the company whose exosome products sickened patients in Nebraska late last year, according to a recent warning letter.

The agency also warned EUCYT for marketing an exosome product COVIXO that it claimed could treat COVID-19.

Paul Knoepfler, PhD, a stem cell expert at the University of California Davis, wrote in a blog post that the June 4 letter “is one of the more lengthy warnings that I’ve seen recently” as it highlights some 13 “major observations.”

(read more…)